miR-96
|
Oncogene
|
Hepatocellular carcinoma
|
Increases proliferation and colony formation
|
FOXO1, FOXO3a
|
[2]
|
miR-96
|
Oncogene
|
Prostate cancer
|
Inhibits zinc uptake
|
ZIP1, ZIP3, ZIP7, ZIP9, ZnT1, ZnT7
|
[3]
|
miR-182
|
miR-183
|
miR-96
|
Oncogene
|
Medullo-blastoma
|
Inhibits apoptosis, destroys DNA repair, promotes cell migration
|
See reference
|
[4]
|
miR-182
|
miR-183
|
miR-96
|
Oncogene
|
Breast cancer
|
Induces proliferation
|
FOXO3a
|
[5]
|
miR-96
|
Oncogene
|
Breast cancer
|
Increases cell number
|
FOXO1
|
[6]
|
miR-182
|
miR-182
|
Oncogene
|
Glioma
|
Promotes glioma cell aggression
|
CYLD
|
[7]
|
miR-182
|
Oncogene
|
Melanoma
|
Promotes cell migration and survival
|
FOXO3
|
[8]
|
miR-183
|
Oncogene
|
Synovial sarcoma
|
Promotes tumor cell migration
|
EGR1
|
[9]
|
PTEN
|
miR-183
|
Oncogene
|
Hepatocellular carcinoma
|
Iinhibits TGF-beta1-induced apoptosis
|
PDCD4
|
[10]
|
miR-96
|
Tumor suppressor
|
Pancreatic cancer
|
Decreases cell invasion, migration and tumor growth
|
KRAS
|
[11]
|
miR-183
|
Tumor suppressor
|
Breast cancer
|
Inhibits migration
|
Ezrin
|
[12]
|
miR-183
|
Tumor suppressor
|
Osteosarcoma
|
Inhibits migration and invasion
|
Ezrin
|
[13]
|
miR-182
|
Tumor suppressor
|
Lung cancer
|
Inhibits cancer cell proliferation
|
RGS17
|
[14]
|